EMB-02

EMB-02 · Shanghai EpimAb Biotherapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EMB-02, covering 2024-05-21 to 2024-05-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of EMB-02 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]